Terns Pharmaceuticals, Inc. — Director's Dealing 2023

Jun 2, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Terns Pharmaceuticals, Inc. (TERN)
CIK: 0001831363
Period of Report: 2023-05-31

Reporting Person: Sundaram Senthil Vel (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-05-31	Common Stock	P	2111.00	$1.41	Acquired	9770.00	Direct

Footnotes

F1: Includes the purchase of 2,111 shares under the Terns Employee Stock Purchase Plan on May 31, 2023.